Advertisement

Topics

Companies Related to "Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer" [Most Relevant Company Matches] - Page: 3 RSS

19:08 EST 16th November 2018 | BioPortfolio

Here are the most relevant search results for "Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Carboplatin Etoposide Plus LBH589 Small Cell Lung Cancer" Companies 51–75 of 5,000+

Relevant

Agennix

Agennix is a privately held biotechnology company whose lead molecule, Talactoferrin Alfa (talactoferrin; TLF), is an immunomodulatory protein. Agennix is currently preparing to initiate Phase III development of oral talactoferrin for cancer, and topical talactoferrin gel for wound healing.Liquid talactoferrin is an oral anti-cancer drug that has shown activity both as monotherapy and in combinati...


OncoMed Pharmaceuticals, Inc.

OncoMed is a clinical development-stage biopharmaceutical company focused on discovering and developing first-in-class monoclonal antibody therapeutics targeting cancer stem cells, or CSCs. Our approach has been to target CSCs, which are the subpopulation of cells in a tumor responsible for driving growth and metastasis of the tumor. CSCs, also known as tumor-initiating cells, exhibit certain pr...

Sense Proteomic Limited

Sense Proteomic Limited is a biomarker discovery company utilising its proprietary protein array technology to discover and commercialise autoantibody biomarkers for cancer and autoimmune diseases. We have developed a novel functional protein array technology which allows thousands of human proteins to be analysed in a single experiment. Our primary focus is on using our technology to discover new...


Tarveda Therapeutics, Inc.

Tarveda Therapeutics, Inc., is a biopharmaceutical company discovering and developing Pentarins™ as a new class of targeted anti-cancer medicines to advance the treatment of patients with solid tumor cancers. Tarveda’s lead Pentarin drug candidate, PEN-221, is a miniaturized biologic drug conjugate that targets the somatostatin receptor for treat...

Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative oncology products to impact the lives of people with cancer. We are currently focusing our development efforts on picoplatin, a new generation platinum therapy that provides a differentiated spectrum of activity and an improved safety profile. An intravenous chem...

Verastem, Inc. Verastem, Inc.

Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK, PI3K/mTOR a...

Medical Acoustics, LLC

Medical Acoustics’ mission is to design, develop and market devices employing acoustic technologies for diagnostic and therapeutic medical applications. The Company’s first product, the patented Lung Flute®, is a revolutionary medical device that is expected to play a significant role in the treatment, diagnosis of, and drug development for lung ...

New Lung Associates

New Lung Associates is a pulmonary group of physicians leading the Lung Transplant Program and the Adult Cystic Fibrosis Program at Tampa General Hospital, a 988-bed acute care hospital in Tampa, Fla. The New Lung Associates team has specialized focus in the care of advanced lung diseases, cystic fibrosis, and lung transplantation. New Lung Associatesâ€...

VisionGate Inc.

VisionGate, Inc. is led by Dr. Alan Nelson, physicist, bioengineer and entrepreneur who developed the world’s first and only automated screening test to detect cervical cancer, marketed today as FocalPoint by Becton Dickinson. VisionGate produces the first automated 3D cell imaging platform, the Cell-CT, which computes high-resolution 3D biosignatures...

Cell Pathways Incorporated

Cell Pathways is a pharmaceutical company focused on the research, development and commercialization of products to prevent cancer and to treat cancer. Cell Pathways' technology may also prove to have applicability beyond the field of cancer.Cell Pathways' technology is based upon its discovery of a novel mechanism which the Company believes, based on its research, can be targeted to induce select...

Genesis Genomics Inc.

Cancer is the leading cause of pre-mature death in Canada, being responsible for almost 1/3 of all potential years of life lost. During their life-time, 2 in 19 women are expected to develop breast cancer, 1 in 18 will develop colorectal cancer, and 1 in 20 will develop lung cancer. Among men, 1 in 9 will develop prostate cancer during their life-time (National Cancer Institute of Canada, 2000).

Fate Therapeutics, Inc.

Fate Therapeutics is interrogating adult stem cell biology and applying induced pluripotent stem cell (iPSC) technology to develop stem cell modulators, small molecule or biologic compounds that guide cell fate for therapeutic purposes. The Company's award-winning, proprietary iPSC technology platform incorporates the most advanced viral, small molecule and protein reprogramming methods and offer...

Elsevier and Cell Press

Cell Press, an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting research and reviews. Each of our titles is viewed as a must-read by the scientific community it serves. Cell Press primary research journals include the flagship journal Cell, as well as Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, S...

National Breast Cancer Awareness Month

In the United States, an estimated 192,370 women and 1,910 men will be diagnosed with new cases of breast cancer in 2009. Breast cancer ranks second as a cause of cancer death in women (after lung cancer). Death rates for breast cancer have steadily decreased in women since 1990, due to progress in both earlier detection and improved treatment. The current five-year survival rate for female breast...

Progen Pharmaceuticals

Progen Pharmaceuticals Limited (NASDAQ:PGLA; ASX: PGL) is a globally focused biotechnology company committed to improving patient outcomes through discovery and development of small molecule-based cancer therapeutics. The company has an intimate understanding of the role of heparan sulfate, a complex sugar, in cancer disease processes and have developed a small-molecule drug development program i...

Panagin Pharmaceuticals Inc.

Panagin Pharmaceuticals Inc., a privately-held biotech company, specializes in the discovery, research, development and commercialization of saponin based anti-cancer drugs. Panagin's proprietary new drug candidates show strong anti-cancer properties against various advanced, metastatic, multi-drug resistant cancers. Panagin's research and clinical programs focus on life-threatening diseases, such...

TP Therapeutics Inc.

TP Therapeutics is a clinical-stage precision oncology company forging a new path for targeted cancer care. Founded in October 2013 by Dr. J. Jean Cui, the lead inventor of Pfizer’s oncology drugs crizotinib and lorlatinib, the company is developing a pipeline of novel drugs that aim to tackle treatment resistance and give new hope to patients who have ...

ProlX Pharmaceuticals, Corp.

ProlX Pharmaceuticals (ProlX) is a biopharmaceutical company dedicated to the discovery of novel therapeutics for the treatment of cancer. The Company is building a diversified pipeline utilizing a target-directed combinatorial chemistry approach to accelerate the design and development of small molecule drug leads. ProlX’s drug discovery program is focused on targeting redox regulation and sur...

Medical Acoustics LLC

Medical Acoustics’ mission is to design and develop devices employing acoustic technologies for diagnostic and therapeutic medical applications. It is a privately held, commercial-stage medical device company located in Buffalo, New York that has been built on ten years of research and development in the science of applied acoustics. The Company...

TetraLogic Pharmaceuticals

TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that discovers and develops small molecule drugs that modulate programmed cell death pathways to treat debilitating diseases and conditions. The Company’s SMAC mimetics neutralize critical blocks in the apoptosis pathway to destroy cancer cells selectively. TetraLogic’s necr...

Allegro Diagnostics Corp.

Allegro Diagnostics’ molecular testing platform utilizes gene expression of normal epithelial cells in the respiratory tract to detect early signs of lung cancer and diseases of the airway. The “field of injury” principle on which the platform is based refers to the detectable molecular changes that occur throughout the respiratory tract in ...

Gemin X Pharmaceuticals, Inc.

Gemin X Pharmaceuticals, Inc., specializes in the discovery and development of novel target-based cancer therapeutics. Gemin X's lead product, obatoclax (GX15-070), is a small molecule, pan-inhibitor of Bcl-2 proteins and is currently in Phase 2 clinical trials. Gemin X's second compound GMX1777, is a potent, small molecule that specifically inhibits nicotinamide phosphoribosyl transferase (NAMPRT...

Lung Therapeutics, Inc.

Lung Therapeutics, Inc. is a pharmaceutical company formed to leverage 25 years of leading research in lung injury and disease by pursuing niche, orphan drug indications for which there is no current effective therapeutic option. Current pipeline programs include LTI-01 Pleural Effusion (PE) with Loculation, LTI-02 Acute Lung Injury (ALI) and LTI-03 Idiopa...

Kinex Pharmaceuticals, LLC

Kinex Pharmaceuticals is developing next generation anti-cancer drugs that target the molecular basis of disease. The Company uses a proprietary technology platform to generate compounds that inhibit the Protein Kinase and Phosphatase family of proteins.Protein kinases and phosphatases are families of proteins that are intimately involved in transmitting signals across the cell membrane. They cont...

Adherex Technologies Incorporated

Adherex Technologies is a biotechnology company developing novel therapeutics based on cell adhesion technologies. Adherex is currently developing a portfolio of biologically active small molecules based on the cadherin family of cell adhesion molecules. Cadherins are the major biological glues that hold tissues intact. They play an important role in maintaining the integrity of tissues and barrie...


More From BioPortfolio on "Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks